Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women

Geoffrey C. Kabat, Mimi Kim, Juhua Luo, Lifang Hou, Jeremy Cetnar, Jean Wactawski-Wende, Thomas E. Rohan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The incidence of cancer of the urinary bladder is three- to five-fold lower in women than in men. This difference may be partially explained by lower exposure to cigarette smoking and occupational chemicals. In addition, female endogenous hormones may also play a protective role in the etiology of this disease. However, limited information is available from cohort studies that have examined reproductive factors and hormone use in relation to the risk of bladder cancer. We assessed the association of menstrual and reproductive factors and exogenous hormone use with the risk of incident transitional cell cancer of the urinary bladder in a cohort of 145 548 postmenopausal women (ages 50-79 years at baseline) enrolled in the Women's Health Initiative. Over 12.7 years of follow-up, 480 cases of transitional cell bladder cancer were identified. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the exposures of interest. Relative to nulliparous women, parous women had a reduced risk of transitional cell cancer: multivariable-adjusted HR 0.77, 95% CI 0.59-1.01; however, there was no clear trend with increasing number of births. Risk was significantly increased in women with a history of at least two miscarriages (HR 1.52, 95% CI 1.15-2.00). Neither other reproductive variables we studied nor the use of exogenous hormones, including type of hormone therapy, were associated with altered risk of bladder cancer. In conclusion, in this large prospective study of postmenopausal women, we found limited evidence for associations of reproductive factors or exogenous hormone use with the risk of bladder cancer.

Original languageEnglish (US)
Pages (from-to)409-416
Number of pages8
JournalEuropean Journal of Cancer Prevention
Volume22
Issue number5
DOIs
StatePublished - Sep 2013

Fingerprint

Urinary Bladder Neoplasms
Hormones
Confidence Intervals
Women's Health
Spontaneous Abortion
Proportional Hazards Models
Cohort Studies
Smoking
Parturition
Prospective Studies
Incidence
Neoplasms

Keywords

  • Bladder cancer
  • Cohort studies
  • Hormone therapy
  • Reproductive factors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women. / Kabat, Geoffrey C.; Kim, Mimi; Luo, Juhua; Hou, Lifang; Cetnar, Jeremy; Wactawski-Wende, Jean; Rohan, Thomas E.

In: European Journal of Cancer Prevention, Vol. 22, No. 5, 09.2013, p. 409-416.

Research output: Contribution to journalArticle

Kabat, Geoffrey C. ; Kim, Mimi ; Luo, Juhua ; Hou, Lifang ; Cetnar, Jeremy ; Wactawski-Wende, Jean ; Rohan, Thomas E. / Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women. In: European Journal of Cancer Prevention. 2013 ; Vol. 22, No. 5. pp. 409-416.
@article{c0e603248d9a4a86b414145d67187dbb,
title = "Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women",
abstract = "The incidence of cancer of the urinary bladder is three- to five-fold lower in women than in men. This difference may be partially explained by lower exposure to cigarette smoking and occupational chemicals. In addition, female endogenous hormones may also play a protective role in the etiology of this disease. However, limited information is available from cohort studies that have examined reproductive factors and hormone use in relation to the risk of bladder cancer. We assessed the association of menstrual and reproductive factors and exogenous hormone use with the risk of incident transitional cell cancer of the urinary bladder in a cohort of 145 548 postmenopausal women (ages 50-79 years at baseline) enrolled in the Women's Health Initiative. Over 12.7 years of follow-up, 480 cases of transitional cell bladder cancer were identified. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95{\%} confidence intervals (CI) for the exposures of interest. Relative to nulliparous women, parous women had a reduced risk of transitional cell cancer: multivariable-adjusted HR 0.77, 95{\%} CI 0.59-1.01; however, there was no clear trend with increasing number of births. Risk was significantly increased in women with a history of at least two miscarriages (HR 1.52, 95{\%} CI 1.15-2.00). Neither other reproductive variables we studied nor the use of exogenous hormones, including type of hormone therapy, were associated with altered risk of bladder cancer. In conclusion, in this large prospective study of postmenopausal women, we found limited evidence for associations of reproductive factors or exogenous hormone use with the risk of bladder cancer.",
keywords = "Bladder cancer, Cohort studies, Hormone therapy, Reproductive factors",
author = "Kabat, {Geoffrey C.} and Mimi Kim and Juhua Luo and Lifang Hou and Jeremy Cetnar and Jean Wactawski-Wende and Rohan, {Thomas E.}",
year = "2013",
month = "9",
doi = "10.1097/CEJ.0b013e32835f3ba3",
language = "English (US)",
volume = "22",
pages = "409--416",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women

AU - Kabat, Geoffrey C.

AU - Kim, Mimi

AU - Luo, Juhua

AU - Hou, Lifang

AU - Cetnar, Jeremy

AU - Wactawski-Wende, Jean

AU - Rohan, Thomas E.

PY - 2013/9

Y1 - 2013/9

N2 - The incidence of cancer of the urinary bladder is three- to five-fold lower in women than in men. This difference may be partially explained by lower exposure to cigarette smoking and occupational chemicals. In addition, female endogenous hormones may also play a protective role in the etiology of this disease. However, limited information is available from cohort studies that have examined reproductive factors and hormone use in relation to the risk of bladder cancer. We assessed the association of menstrual and reproductive factors and exogenous hormone use with the risk of incident transitional cell cancer of the urinary bladder in a cohort of 145 548 postmenopausal women (ages 50-79 years at baseline) enrolled in the Women's Health Initiative. Over 12.7 years of follow-up, 480 cases of transitional cell bladder cancer were identified. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the exposures of interest. Relative to nulliparous women, parous women had a reduced risk of transitional cell cancer: multivariable-adjusted HR 0.77, 95% CI 0.59-1.01; however, there was no clear trend with increasing number of births. Risk was significantly increased in women with a history of at least two miscarriages (HR 1.52, 95% CI 1.15-2.00). Neither other reproductive variables we studied nor the use of exogenous hormones, including type of hormone therapy, were associated with altered risk of bladder cancer. In conclusion, in this large prospective study of postmenopausal women, we found limited evidence for associations of reproductive factors or exogenous hormone use with the risk of bladder cancer.

AB - The incidence of cancer of the urinary bladder is three- to five-fold lower in women than in men. This difference may be partially explained by lower exposure to cigarette smoking and occupational chemicals. In addition, female endogenous hormones may also play a protective role in the etiology of this disease. However, limited information is available from cohort studies that have examined reproductive factors and hormone use in relation to the risk of bladder cancer. We assessed the association of menstrual and reproductive factors and exogenous hormone use with the risk of incident transitional cell cancer of the urinary bladder in a cohort of 145 548 postmenopausal women (ages 50-79 years at baseline) enrolled in the Women's Health Initiative. Over 12.7 years of follow-up, 480 cases of transitional cell bladder cancer were identified. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the exposures of interest. Relative to nulliparous women, parous women had a reduced risk of transitional cell cancer: multivariable-adjusted HR 0.77, 95% CI 0.59-1.01; however, there was no clear trend with increasing number of births. Risk was significantly increased in women with a history of at least two miscarriages (HR 1.52, 95% CI 1.15-2.00). Neither other reproductive variables we studied nor the use of exogenous hormones, including type of hormone therapy, were associated with altered risk of bladder cancer. In conclusion, in this large prospective study of postmenopausal women, we found limited evidence for associations of reproductive factors or exogenous hormone use with the risk of bladder cancer.

KW - Bladder cancer

KW - Cohort studies

KW - Hormone therapy

KW - Reproductive factors

UR - http://www.scopus.com/inward/record.url?scp=84882267589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882267589&partnerID=8YFLogxK

U2 - 10.1097/CEJ.0b013e32835f3ba3

DO - 10.1097/CEJ.0b013e32835f3ba3

M3 - Article

C2 - 23442343

AN - SCOPUS:84882267589

VL - 22

SP - 409

EP - 416

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - 5

ER -